Objective: To validate a detailed semiquantitative food frequency questionnaire designed to measure habitual fish and seafood consumption. Design: Cross-sectional validation study using an independent biomarker of fish consumption. Setting: Perth metropolitan area, Western Australia. Subjects: Ninety-one healthy volunteers of both sexes aged 21-75 years. Methods: Participants completed the questionnaire and provided a fasting blood sample for erythrocyte membrane omega-3 fatty acid (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) analysis. The questionnaire was then validated by linear regression analysis of EPA and DHA levels on categories of fish and seafood and overall consumption, adjusted for age, sex, smoking status, body mass index (BMI) and alcohol intake. Results: Regression coefficients were statistically significant for most fish and seafood items with both EPA and DHA. The strongest association was observed between oily fish and EPA, whereas no significant association was observed between lean fish and omega-3 fatty acids. Variation in omega-3 fatty acids was best accounted for by a model containing variables representing different categories of fish and seafood consumption (R 2 0.484), rather than a single variable representing overall fish and seafood consumption (R 2 0.313). Conclusions: This study confirms that the varying content of omega-3 fatty acids in foods are reflected in omega-3 biomarkers, and that the questionnaire is a valid measure of fish consumption that enables differentiation between cooking and processing methods and oily versus lean fish intake.
Introduction
Increasingly more research is being conducted into the potential health benefits of eating fish, with evidence to suggest that dietary fish may play a protective role in diseases including cardiovascular disease, cancer, asthma and atopy (Caygill et al., 1996; Marckmann and Gronbaek 1999; Kobayashi et al., 1999; Stoneham et al., 2000; Kris-Etherton et al., 2002; Devereux and Seaton, 2003) . The mechanism for this benefit has been proposed to be related to the content of omega-3 fatty acids in fish.
However, results from studies of fish consumption as a protective factor in the development of chronic disease have been inconsistent. Reasons suggested for this include (a) deficiencies in the methods of measurement of fish consumption such as lack of differentiation between types of fish, particularly fatty versus lean fish, and variations in cooking and preserving methods; and (b) studies of fish consumption and disease in populations that overall do not consume high enough quantities of fish for a protective effect to be observed (Terry et al., 2003) . The latter could be partially explained by the use of brief questionnaires that lack detail and do not capture all foods containing fish, in countries where less fresh and more processed fish and seafood products are consumed.
Food frequency questionnaires (FFQs) can be tested for validity using a variety of techniques. The use of an independent biomarker provides a validation tool with a measurement error independent of the errors of dietary record methods (Rasmussen et al., 2001 ). An appropriate biomarker for the validation of fish consumption is marine origin omega-3 polyunsaturated fatty acids (PUFAs), eicosapentanoic acid (EPA) and docosahexaenoic acid (DHA), because fish is the major source of EPA and DHA in the diet (Arab, 2003) , and the conversion of other PUFAs into EPA and DHA in humans is inefficient (Davis and Kris-Etherton, 2003) . Levels of these omega-3 PUFAs can therefore be assumed to reflect the consumption of fish as a food group (Arab, 2003) . While the most commonly used biomarker medium for validation studies of fish consumption has been plasma phospholipid PUFAs, erythrocyte membrane (RBC) measures may be more appropriate because erythrocytes are incapable of de novo fatty acid synthesis or modification of PUFAs to form EPA and DHA (Di Marino et al., 2000) and are less subject to rapid fluctuations of PUFA content caused by fish meals (Arab, 2003) .
Few validation studies employing the use of an independent biomarker to test detailed semiquantitative food frequency questionnaires of fish consumption have been published, and those studies have tended to be conducted in countries with higher fish consumption and/or higher consumption of cold water fish. Validation studies in Australia have either used less detailed questionnaires or have tested validity in populations with more restricted age ranges (Woods et al., 2002; Oddy et al., 2004) . Therefore, we developed and tested a detailed questionnaire to measure fish intake for validity. The questionnaire was designed to reflect locally consumed fish and seafood products and to enable the distinction between oily and lean fish, cooking methods, finfish and seafood and fresh and processed fish, and to be suitable for a broader age range included in epidemiological studies of modern diseases such as cancer.
Methods
Questionnaire design and development Details of the design and development of the questionnaire have been reported elsewhere (Mina et al., 2006, submitted manuscript) . Briefly, the content of the questionnaire was based on an existing validated dietary questionnaire from Norway (Hjartaker et al., 1997) . Adjustments to content and formatting were made based on consultation with local experts in fish consumption and results from a short pilot of the questionnaire. The final questionnaire consisted of three sections collecting information on demographic and lifestyle factors, consumption of fresh fish (20 species), processed fish and seafood (18 items), fresh seafood (seven items), omega-3 fortified foods (five items) and supplements and qualitative information regarding changes of type and amount of fish intake over time. Fish and seafood items included in the second section were modified from the original questionnaire to reflect locally caught and marketed fresh fish and availability of processed items on supermarket shelves.
Questions on food items were designed so as to collect information on both portion size and frequency of consumption in order to estimate consumption in grams per week. For fresh and frozen fillet portion size, a single question was included, supported by photographs of fish portions, asking participants to estimate their usual serving size. For other food items, participants were asked to indicate whether they ate a small, medium or large serving and were given a description of a medium serving size. The FFQ was designed to measure usual fish consumption 2 months earlier; participants were asked to refer to their consumption for a particular month in order to make this conceptually easier.
Recruitment
Healthy volunteers aged 21-75 years from the Perth metropolitan area were recruited to complete the developed questionnaire and provide a fasting blood sample for omega-3 PUFA analysis, between March and November 2005. Recruitment was facilitated by a short advertisement circulated by local fish markets, radio broadcasts and websites, state-wide and local newspapers and staff and student mailing lists at the university. The majority of participants were recruited via a feature article about fish and its potential health benefits in a major Perth newspaper over the Easter weekend. These methods were chosen in order to maximize the response from volunteers and as a consequence the study sample was biased towards moderate-to-high consumers of fish.
Potential participants were invited to contact the study coordinator by telephone or email, at which time they were screened to ensure they met health and age requirements. If eligible, potential participants were posted a study pack consisting of instructions for the questionnaire and blood collection, the questionnaire, consent form, blood collection form and a reply paid envelope for the return of the questionnaire. A reminder letter was posted 1 month later to those who had not returned a questionnaire. Additionally, a random sample of those who did not respond to the reminder and who had not contacted the study coordinator to register that they had withdrawn from the study were resent the study pack in November 2005.
For the purposes of the current study, subjects were eligible if they did not have a history of heart disease, cancer (not including skin cancer), severe inflammatory diseases requiring regular medication, emphysema or asthma, diabetes, severe gastrointestinal disease or mental illness (depression, schizophrenia or personality disorder). Those who had recently altered their diet or were pregnant were also deemed ineligible. Because of the high prevalence of mild joint pain, those with joint pain not requiring regular medication or inhibiting daily activities were not excluded. Potential participants with a history of mild depression not requiring hospitalization were included. All of these exclusion criteria were chosen either because they have been associated with fish or omega-3 consumption or have the potential to affect omega-3 PUFA levels in the blood (Hunter et al., 1992; Parra et al., 2002) . Information regarding demographic and lifestyle factors (age, sex, body mass index (BMI), alcohol intake, education, smoking status, race, exercise, use of lipidlowering medication) that might affect omega-3 PUFA levels was also collected but not used to exclude volunteers from participation.
Participants were instructed to have their blood sample taken within 2 weeks of completing the questionnaire to ensure that the diet recorded in the questionnaire was likely to reflect that indicated by omega-3 biomarkers. Participants were asked about their fish consumption 2 months earlier, to coincide with the omega-3 fatty acid levels indicated by measuring RBC fatty acids (Katan et al., 1997) .
Blood collection, processing and analysis Fasting blood samples were collected in heparinized tubes by trained phlebotomists at metropolitan collection centres and transferred to a central laboratory. Samples were centrifuged and the plasma fraction removed and retained for analysis. The erythrocyte fraction was washed and packed. Processed plasma and erythrocyte samples were stored at À80 1C until transferred to a separate laboratory for PUFA analysis by gas liquid chromatography using a Hewlett-Packard model 5980A gas chromatograph (Mori et al., 2000) . Individual fatty acids were calculated as a relative percentage with the evaluated fatty acids set at 100%.
Statistical analysis
Missing values for BMI, resulting from missing data on either height or weight for five subjects, were replaced with means, and four subjects who did not indicate their race were categorized as 'unknown'. Missing entries for frequency of consumption were assumed to represent zero consumption for that item (a tendency to leave blanks rather than indicate zero consumption was observed in 16 questionnaires). Missing entries for portion size were replaced with medium portion size (mean number of missing values per individual item was 1.76), or mean portion size in the case of fresh/ frozen fish fillets (n ¼ 3). No participants were excluded because of missing data. Frequency and portion size data were converted into serves per week and grams per week consumption for each questionnaire item. In order to make comparisons with previously published results on fish and seafood item validity, aggregate variables representing groups of foods were generated by summing serves per week or grams per week for individual items.
As the differentiation of oily and lean fish is of particular interest, variables for grams per week and serves per week of fresh oily fish were also generated. Species included in this definition were Atlantic salmon, Spanish mackerel, Mullet, Grouper/cod, Swordfish, Tuna, Orange Roughie, Patagonian Tooth fish, and were chosen based on a total fat content of 42% (considered to be medium to high fat content by a major Australian research body (Mooney et al., 2002) . Although local Tuna and Mullet did not meet this criterion, they were included as an oily fish because they are generally recognized as such.
For the purpose of linear regression, serves and grams per week fish item variables and EPA and DHA variables were log transformed according to log (X þ 1) because of the skewed nature of both the fish consumption data and the erythrocyte membrane EPA and DHA levels. Demographic variables were not transformed.
Validity of the questionnaire was tested using linear regression techniques of erythrocyte membrane EPA and DHA levels on individual fish items consumed by more than 10% of participants and also on various aggregate measures of fish consumption after adjustment for age, sex, BMI, smoking status and alcohol consumption. R 2 values from regression models were used to assess the variation in EPA and DHA levels accounted for by fish consumption variables.
Multicollinearity in regression models with multiple fish consumption variables was investigated and not found to be a problem. Spearman rank correlation coefficients were also calculated to enable comparisons with previously published literature on validity testing of food frequency questionnaires with independent biomarkers. Analysis was conducted using STATA v9.0. and SPSS v14 statistical packages. Ethics approval for this study was obtained from the Human Research Ethics Committee of the University of Western Australia.
Results
Of 175 people who indicated interest in participating in the study and were eligible, 112 completed a questionnaire and provided a fasting blood sample. Three were later discovered to be ineligible for health reasons (asthma, systemic lupus erythematosus and diabetes). After excluding those who took fish oil; data for 91 subjects were available for analysis. Fifty-six percent of participants were women and the mean age was 50 years (Table 1) . Study participants were generally of European descent, well-educated with healthy lifestyles. Fifty-two of those who registered interest were sent a reminder letter at 1 month. Despite this, no questionnaire or indication of ineligibility/withdrawal was received from 38 people. After re-sending the study pack to a random sample of these (n ¼ 18), two participants returned a completed questionnaire and provided a blood sample. Therefore, a total of 36 people who initially registered interest by email or telephone did not respond. Information collected at the time of initial contact indicated that non-responders were as likely to be male as female and were typically younger than the study population (mean age 44 years).
Crude and geometric means for erythrocyte membrane EPA and DHA are presented in Table 2 . Linear regression analysis of EPA and DHA on lifestyle and demographic factors (age, sex, BMI, smoking status, use of lipid-lowering medications, exercise, alcohol intake and education level) demonstrated a significant association with age and total alcohol intake (grams per week). Any further regression analysis of fish consumption and EPA or DHA, therefore, was adjusted for these factors, as well as sex, smoking status (never versus ever) and BMI for comparability with other validation studies of fish consumption and studies of the association between chronic disease and fish consumption.
Mean serves and grams per week of aggregates of fish and seafood consumption are presented in Table 3 , arranged under four main groups of foods (fresh/frozen fish, processed fish and seafood, seafood and fortified foods). Participants most frequently and commonly ate fresh/frozen fish fillets, and tended to eat these grilled or baked rather than fried. Processed fish and seafood, which encompassed all canned, preserved and preprepared foods containing fish and seafood was the next most consumed group, but this is probably because it encompasses a broad range of foods. Included in the processed group is canned fish and seafood (including tuna and salmon), which was the fourth most frequently consumed of the aggregates. Smoked, dried and salted fish was the aggregate least frequently consumed, whereas omega-3 fortified foods were the least commonly consumed.
Spearman rank correlation coefficients calculated for individual fresh fish, fresh seafood and processed fish and seafood ranged between À0.26 and 0.31 for EPA and À0.20 and 0.28 for DHA. Spearman correlation coefficients and linear regression analysis results (adjusted for age, sex, BMI, smoking status and alcohol intake) for aggregate measures are presented in Table 4 .
Fried fish and lean fish aggregates had low Spearman correlations and R 2 values. In analysis of individual questionnaire items, lean fried fishes tended to have negative Spearman rank correlations, whereas fatty fried fish tended to have positive correlations, with the strongest positive correlation noted for Australian salmon and DHA, and the strongest negative observed for hake and EPA. Spearman correlations were also more likely to be negative for lean fish varieties of grilled/baked fish individual items. Fresh fish and oily fish aggregates strongly and significantly associated with EPA and DHA, as demonstrated by the Spearman correlations and linear regression coefficients in Table 4 . Spearman correlations for mullet, Atlantic salmon, tuna, swordfish, Spanish mackerel and Australian salmon as individual items with EPA or DHA were amongst the highest correlations for fish items. All of these, except for Australian salmon, were identified before analysis as oily fish. Food Frequency questionnaire to measure fish consumption K Mina et al
All individual seafood items (except crab) and seafood as a group had positive correlations with DHA and EPA, however stronger correlations for individual seafoods tended to occur with EPA.
Based on correlation coefficients, as a group, canned fish and seafood was more strongly associated with DHA than EPA, whereas smoked, salted or dried fish was higly correlated with both. The only individual processed fish and seafood item significantly correlated with EPA and DHA was cold smoked salmon, which also had the largest Spearman coefficients. Canned tuna and salmon correlated negatively with EPA and positively with DHA (but not significantly so).
Finally, the ratio of grams of oily fish to grams of lean fish consumption was positively associated with both EPA and DHA, that is as consumption of oily fish increases relative to lean fish, so do levels of EPA and DHA. This relationship was stronger for EPA than DHA. Table 5 compares results based on serves per week and grams per week for four major food groups. Spearman correlation coefficients were consistently lower for serves per week than grams per week consumption, although this was less marked for processed foods. The R 2 values demonstrated that serves per week and grams per week of these major food groups account for similar variation in RBC EPA levels, albeit slightly less so for grams per week consumption. Table 6 summarizes the results of multiple linear regression analysis of EPA and DHA with aggregate variables representing major groups of fish and seafood consumption, and with a single measure of habitual fish consumption (sum of grams per week of all fresh and processed fish and seafood). This analysis was carried out as an indication of how well the questionnaire as a whole validly captured fish and seafood consumption. Fish and seafood, adjusted for age, sex, BMI, smoking status and alcohol consumption, accounted for greater variation in RBC EPA than DHA. However, addition of multiple fish and seafood variables to a base model of age, sex, BMI, smoking and alcohol resulted in improvements of R 2 values closer in magnitude for EPA and DHA (model 1), and a greater improvement in the R 2 value was noted for Food Frequency questionnaire to measure fish consumption K Mina et al DHA when a single variable for fish consumption was added (model 2). Also of note is that while fresh seafood was significantly associated with EPA and DHA in models containing seafood as the only fish consumption item (Table 4) , this is not the case when it is contained in a model with other fish and seafood groups. Most importantly, it was observed that more of the variation in EPA and DHA can be accounted for in a model that separately itemizes different types of fish and seafood rather than including all fish and seafood consumption as a single variable (habitual fish consumption).
Discussion
This study confirms that our detailed semiquantitative food frequency questionnaire is a valid measuring tool suitable for ranking subjects by habitual fish consumption. Various studies have been published that present crosssectional studies of correlations between blood measures of omega-3 PUFA EPA and DHA and fish consumption, all of which have used plasma measures. Most report Pearson and Spearman rank correlations as measures of validity of total fish consumption ranging between 0.09 and 0.72 (Moilanen et al., 1992; Svensson et al., 1993; Nikkari et al., 1995; Andersen et al., 1996; Hjartaker et al., 1997; Sasaki et al., 2000; Woods et al., 2002) . Our results are comparable with these, although our correlations are lower than those reported by an ecological study that used erythrocyte membrane measures (r ¼ 0.64 with DHA and r ¼ 0.59 with EPA) (Wang et al., 2003) .
We were able to identify five studies in the literature that used multiple linear regression analysis to assess the correlation between fish and seafood and omega-3 PUFA's (Bonaa et al., 1992; Bjerve et al., 1993; Svensson et al., 1993; Hjartaker et al., 1997; Amiano et al., 2001) . A sixth study used generalized linear modelling (Wakai et al., 2005) . All used plasma measures of EPA and/or DHA (phospholipids or phosphatidylcholine) as biomarkers. As a measure of fish intake, three studies used frequency of fish meals per week but did not always indicate if this included seafood (Bonaa et al., 1992; Bjerve et al., 1993; Wakai et al., 2005) , two used categories of fish and seafood in frequency and quantities per week (Hjartaker et al., 1997; Amiano et al., 2001) , and the sixth used quantities of fish consumed per week (Svensson et al., 1993) . Four models included combinations of variables to adjust for the effects of age, sex, BMI, smoking, alcohol consumption and vegetable intake (Bonaa et al., 1992; Bjerve et al., 1993; Amiano et al., 2001; Wakai et al., 2005) .
These six studies found that overall fish consumption was positively correlated with plasma measures of omega-3 fatty acids, regardless of whether fish was entered as a serves per week or grams per week variable. However, only two studies quantified their results (adjusted R 2 values of 0.17-0.26) (Bonaa et al., 1992; Hjartaker et al., 1997) . Within studies, portion size did not appear to have a consistent effect: Hjartaker et al. (1997) found an improvement in the magnitude of correlations with biomarkers for some categories of fish consumption but not for others. This, in conjunction with our findings regarding the effect of portion size on R 2 values, would suggest that the additional burden placed on participants by inquiring about individual portion sizes is unnecessary when estimating consumption of fish and seafoods. However, to adequately test the effect of portion size on fish consumption estimates, ideally two different FFQs would need to be administered to participants in order to assess the interpretation of questions on frequency separately and in addition to portion size. Our findings from multiple regression analysis would suggest that it is important to ask not only about fresh fish but also other types of fish and seafood in order to truly capture overall fish consumption. Various authors have commented that, given the higher content of omega-3 PUFA's in fatty fish, differentiation between lean and fatty fish may be of value (Godley et al., 1996; Woods et al., 2002; Wakai et al., 2005) . Although previous validation studies have found significant associations between plasma phospholipid omega-3 PUFAs and fish intake despite reportedly low consumption of fatty fish (Bonaa et al., 1992; Amiano et al., 2001) , other studies that have assessed oily and lean fish separately have found that oily fish, but not lean, has a significant correlation with omega-3 PUFAs (Svensson et al., 1993; Hjartaker et al., 1997) . Our study goes a step further to reveal a significant negative correlation between lean fish and omega-3. It is not clear as to why this was observed, however it may be related to the relative proportions of lean and fatty fish in the diet, as suggested by the strong positive correlation between an increasing ratio of oily to lean fish consumption with increasing RBC omega-3. Additionally, while fresh fatty fish correlates strongly with EPA, the same cannot be said for tinned fatty fishes (tuna and salmon). From an epidemiological point of view, this information is important for the design of future questionnaires on fish consumption; from a health promotional point of view our findings will assist health professionals aiming to encourage consumption of types of fish that will most successfully boost omega-3 PUFA levels for the purpose of improving health.
We found that fish consumption, in a model adjusted for age, sex, BMI, smoking status and alcohol consumption, accounted for more variation in EPA than DHA as judged by the R 2 value for the full models. This is consistent with other validation studies (Bonaa et al., 1992; Hjartaker et al., 1997) that have assessed this variation in a similar manner. Studies of effects on RBC fatty acids with fish oil supplementation have also shown EPA to be a better indicator of fish and fish oil intake (Brown et al., 1991) . However, our analysis would suggest that it is incorrect to assume that this difference in variation of EPA and DHA is due to fish consumption reflecting to a lesser extent in DHA levels. When model 1 for EPA is compared with DHA, the discrepancy in variation accounted for by the model is more due to differences in the adjustment variables than fish consumption. In model 2, fish consumption actually accounts for a greater magnitude of improvement in the R 2 value for DHA than EPA.
Previous studies of erythrocyte levels of DHA have shown that DHA changes more erratically over time (Katan et al., 1997) , suggesting that DHA is under different homeostatic and metabolic control to EPA. This, in conjunction with our observations that factors including age, sex and BMI have less impact on DHA levels than EPA levels, may indicate that the differences in variation accounted for by EPA and DHA are a function of biological and metabolic factors and other dietary factors not included in our modelling.
Compared to Hjartaker et al., we observed a stronger correlation between DHA and fatty fish. In addition, reanalysis of our data using similar methods (including participants taking fish oil and adjusting for fish oil consumption), enabled us to demonstrate a statistically significant association between DHA and fatty fish in the full regression model where they did not. Australian research of local fishes (Mooney et al., 2002) has found that Australian finfish generally have higher relative levels of DHA than fish from the Northern hemisphere, which might explain this finding. This is supported by our results and another Australian study (Woods et al., 2002) that found stronger correlations (unadjusted) between fish intake and plasma DHA than EPA.
We did not find a strong association between seafood and EPA or DHA in the full multiple regression models, which is consistent with another study that assessed shellfish separately to finfish (Hjartaker et al., 1997) . Although significant correlations were found between EPA and DHA for individual seafood items, we would not necessarily expect to find an association between seafood and omega-3 PUFA blood levels as it is recognized that seafood contains less EPA and DHA than fish (Mooney et al., 2002) . Our findings reinforce the importance of distinguishing between finfish and seafood in dietary questionnaires.
In the present study, we collected information on sex, age, height, weight, smoking, alcohol intake, exercise, lipidlowering medication and fish oil supplementation, as well as detailed information on fish consumption. We chose to include age, sex, BMI, smoking status and alcohol consumption in the regression analysis. Univariate analysis of these factors only identified age and alcohol as having a significant association with RBC EPA and DHA. Studies other than ours have also failed to find any effect of these factors on blood EPA and DHA levels (Ma et al., 1995) . However, the decision was made to include BMI and smoking because of a potential effect of fat reservoirs and smoking on blood lipid levels (Wood et al., 1987; Bonaa et al., 1992; Lussier-Cacan et al., 2002) , and sex because this factor, in combination with age, accounts for most of the inter-person variation in energy and nutrient intakes (Willett, 1990) .
Total energy intake was not adjusted for in our analysis. However, it may be important to consider total energy intake because it tends to be positively correlated with most nutrients and therefore is a source of error in analysis (Willett, 1990 ). We chose not to administer an additional questionnaire to measure energy intake so as not to unnecessarily burden study participants, but instead adjust for variation in energy intake indirectly by including age, sex and BMI in the multiple regression analysis. Two validation studies that adjusted for total energy intake actually found improved correlations between plasma EPA and fish intake or omega-3 intake (Nikkari et al., 1995; Sasaki et al., 2000) , and therefore it would be reasonable to assume, given these findings and the lack of a positive correlation of BMI and exercise (reflective of total energy intake) (Willett, 1990) with omega-3 levels, that our correlations are not artificially high because of a failure to adjust for energy intake. Ultimately, researchers investigating associations between fish consumption and disease may not choose to adjust their analyses for energy intake, and we have demonstrated that the current FFQ is suitable for use under those circumstances.
We achieved a population sample with an appropriate age range for most chronic diseases and that had good representation of both men and women. However, other characteristics of our sample would suggest that most participants were reasonably health conscious, well educated, higher than average consumers of fish and seafood, and likely to have a great awareness of types of fish and seafood, and the performance of the FFQ in the general population or in populations that consume lower levels of fish may not be as good. Also, the design of the questionnaire to include local varieties of fish probably limits the use of this validated questionnaire to studies of chronic disease and fish consumption in Australia. However, the process of validating the questionnaire has demonstrated that when using omega-3 biomarkers to validate fish as a food group, observed correlations will be affected by relative proportions of fatty and lean fish, and fresh fish, processed fish and seafood consumed.
